Case Report
Published on 13 Oct 2025
Case Report: Management of a BCR-ABL1-positive high-risk rhabdomyosarcoma patient using tyrosine kinase inhibitors
in Precision Medicine
- 394 views
Case Report
Published on 13 Oct 2025
in Precision Medicine
Editorial
Published on 13 Oct 2025
in Advanced Oxidation Processes
Review
Published on 13 Oct 2025
in Nanobiotechnology
Original Research
Published on 13 Oct 2025
in Microbiological Chemistry and Geomicrobiology
Original Research
Published on 13 Oct 2025
in Mucosal Immunity
Original Research
Published on 13 Oct 2025
in Ethnopharmacology
Original Research
Published on 13 Oct 2025
in Extra-intestinal Microbiome
Original Research
Published on 13 Oct 2025
in Public Mental Health
Original Research
Published on 13 Oct 2025
in Cancer Endocrinology
Original Research
Published on 13 Oct 2025
in Molecular and Cellular Pathology
Original Research
Published on 13 Oct 2025
in Breast Cancer
Original Research
Published on 13 Oct 2025
in Children and Health
Original Research
Published on 13 Oct 2025
in Infectious Agents and Disease
Original Research
Published on 13 Oct 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Oct 2025
in Epigenomics and Epigenetics
Review
Published on 13 Oct 2025
in Experimental Pharmacology and Drug Discovery